Home › Neurofibrosarcoma › Washington
Neurofibrosarcoma clinical trials in Washington, DC
6 studies for Neurofibrosarcoma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
SPEARHEAD-3 Pediatric Study
RecruitingPhase 1/2
- National Institutes of Health, Bethesda · 7 mi away
Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
RecruitingPhase 1/2
- Children's National Hospital, Washington D.C.
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
RecruitingPhase 2
- Children's National Hospital (Data Collection Only), Washington D.C.
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
RecruitingObservational study
- National Institutes of Health (NIH), Bethesda · 7 mi away
Neurofibrosarcoma trials in other cities
- New York City, NY6 studies
- St. Louis, MO4 studies
- Boston, MA4 studies
- Mountain View, CA3 studies
- Cincinnati, OH3 studies
- Houston, TX3 studies
- Chicago, IL3 studies
- Queens, NY3 studies
- Edison, NJ3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.